Data / Form D filings / Basking Biosciences, Inc.
Basking Biosciences, Inc.: Form D filings
Basking Biosciences, Inc., a biotechnology company in Cary, NC, filed 3 Form D notices with the SEC between 2020 and 2025. The latest, on October 22, 2025, reports $55 million sold of a $55 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 964 High House Rd #3268, Cary, NC, 27513
- Phone
- (919) 345-7933
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1824142
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | Amendment | $55,000,000 | $55,000,000 | 11 | Oct 31, 2023 | sec.gov | |
| Nov 15, 2023 | New notice | $55,000,000 | $27,500,017 | $27,499,983 | 11 | Oct 31, 2023 | sec.gov |
| Sep 10, 2020 | New notice | $7,000,000 | $1,901,122 | $5,098,878 | 6 | Aug 28, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Hannah Chang | Director | |
| Julia Owens | Executive Officer, Director, Promoter | |
| Aiden Aceves | Director | |
| David Adair | Director | |
| Steve Gillis | Director | |
| Ari Nowacek | Director | |
| Shahid Nimjee | Director | |
| Thomas Needham | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Oct 20, 2025 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Basking Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.